Abstract
T-cell growth factor (TCGF or interleukin-2) is an inducible glycoprotein hormone of molecular weight 15,000 (ref. 1) synthesized and secreted by T lymphocytes following activation with antigen or mitogen2,3. TCGF is required for proliferation and expansion of T cells following antigen encounter4,5 and to maintain them in long-term culture in vitro6–9. Full expression of the human immune response requires both the induction of TCGF synthesis and the formation of specific TCGF membrane receptors10,11. Monoclonal antibodies binding TCGF have been prepared12,13. In contrast, antibodies specific for the TCGF membrane receptor have not been identified, nor has the receptor been characterized. We have prepared a monoclonal antibody, termed anti-Tac14,15, which appears to bind to the human membrane receptor for TCGF. In support of this, we now demonstrate that anti-Tac suppresses TCGF induced proliferation of T cells and blocks binding of radiolabelled TCGF to cells from a cloned human continuous T-cell line. Also we have partially purified and characterized the putative TCGF receptor. This receptor is a glycoprotein with a molecular weight (Mr) of 47,000–53,000.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Smith, K. A. Immun. Rev. 51, 337–357 (1980).
Gillis, S., Ferm, M. M., Ou, W. & Smith, K. A. J. Immun. 120, 2027–2032 (1978).
Anderson, J., Gröonvik, K-O., Larsson, E-L. & Coutinho, A. Eur. J. Immun. 9, 581–587 (1979).
Mier, J. W. & Gallo, R. C. Proc. natn. Acad. Sci. U.S.A. 77, 6134–6138 (1980).
Smith, K. A., Gillis, S. & Gallo, R. C. in The Molecular Basis of Immune Cell Function (ed Kaplan, J. G.) 223 (Elsevier, New York, 1979).
Morgan, D. A., Ruscetti, F. W. & Gallo, R. C. Science 193, 1007–1008 (1976).
Ruscetti, F. W., Morgan, A. D. & Gallo, R. C. J. Immun. 119, 131–138 (1977).
Lotze, M. T., Strausser, J. L. & Rosenberg, S. A. J. Immun. 124, 2972–2978 (1980).
Kurnick, J. T. et al. J. Immun. 122, 1255–1260 (1979).
Robb, R. J., Munck, A. & Smith, K. A. J. exp. Med. 154, 1455–1474 (1981).
Poiesz, B. J., Ruscetti, F. W., Mier, J. W., Woods, A. M. & Gallo, R. C. Proc. natn. Acad. Sci. U.S.A. 77, 6815–6819 (1980).
Gillis, S. & Henney, C. S. J. Immun. 126, 1978–1984 (1981).
Stadler, B. M. et al. Prog. Cancer Res. Ther. 20, 69–76 (1981).
Uchiyama, T., Broder, S. & Waldmann, T. A. J. Immun. 126, 1393–1397 (1981).
Uchiyama, T., Nelson, D. L., Fleisher, T. A. & Waldmann, T. A. J. Immun. 126, 1398–1403 (1981).
Ey, P. L., Prowse, S. J. & Jenkin, C. R. Immunochemistry 15, 429–436 (1978).
Gazdar, A. F. et al. Blood 55, 409–417 (1980).
Gootenberg, J. E., Ruscetti, F. W., Mier, J. W., Gazdar, A. & Gallo, R. C. J. exp. Med. 154, 1403–1418 (1981).
Poiesz, B. J., Ruscetti, F. W. Reitz, M. S., Kalyanaraman, V. S. & Gallo, R. C. Nature 294, 268–271 (1981).
Reinherz, E. L., Kung, P. C., Goldstein, G., Levey, R. H. & Schlossman, S. F. Proc. natn. Acad. Sci. U.S.A. 77, 1588–1592 (1980).
Phillips, H. J. in Tissue Culture: Methods and Applications (eds Kruse, P. F. & Patterson, M. J.) 406 (Academic, New York, 1973).
Gillis, S. & Watson, J. J. exp. Med. 152, 1709–1719 (1980).
Oliver, J. M. in Immune Recognition (ed. Rosenthal, A. S.) 445–472 (Academic, New York, 1975).
Rodbard, D. Adv. exp. Med. Biol. 36, 289–326 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leonard, W., Depper, J., Uchiyama, T. et al. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature 300, 267–269 (1982). https://doi.org/10.1038/300267a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/300267a0
This article is cited by
-
Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis
Nature Reviews Neurology (2013)
-
Identification of novel Interleukin-2 inhibitors through computational approaches
Molecular Diversity (2013)
-
Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages
Nature Immunology (2011)
-
Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma
Oncogene (2007)
-
Anti-Tac (daclizumab, Zenapax) in the Treatment of Leukemia, Autoimmune Diseases, and in the Prevention of Allograft Rejection: A 25-Year Personal Odyssey
Journal of Clinical Immunology (2007)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.